Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products

December 13, 2022

https://www.globenewswire.com/news-release/2022/12/13/2572655/0/en/Sharps-Technology-and-Nephron-Pharmaceuticals-Sign-Distribution-Agreement-for-its-Innovative-Syringe-Products.html

Company anticipates products to be available in the first quarter of 2023 with initial revenue from this agreement expected in the first half of the year

Strengthens the collaboration between Sharps and Nephron to advance the previously announced Inject-EZ startup in South Carolina in early 2023

Read more at globenewswire.com

Related news for (STSS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.